ORCID as entered in ROS

Select Publications
2021, 'WS02.4 Evaluating the role of short chain fatty acids in cystic fibrosis', Vol. 20, pp. S4 - S4, http://dx.doi.org/10.1016/s1569-1993(21)00924-3
,2020, 'WS03.6 Does the cystic fibrosis diet contribute to intestinal dysbiosis?', Vol. 19, pp. S6 - S6, http://dx.doi.org/10.1016/s1569-1993(20)30182-x
,2015, 'FAECAL HUMAN BETA-DEFENSIN 2 LEVELS IN CHILDREN WITH CYSTIC FIBROSIS', Vol. 50, pp. 406 - 407, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360791500636&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'ACUTE CHANGES IN THE LUNG CLEARANCE INDEX AFTER PHYSIOTHERAPY IN CHILDREN WITH CYSTIC FIBROSIS', Vol. 20, pp. 112 - 112, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'CPAP CAN DECREASE NEURAL RESPIRATORY DRIVE (NRD) AS MEASURED BY SURFACE ELECTROMYOGRAM OF THE DIAPHRAGM (SEMGDI) IN CHILDREN WITH SLEEP-DISORDERED BREATHING', Vol. 20, pp. 91 - 91, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400236&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'THE PRESENTING SYMPTOMS OF PRIMARY CILIARY DYSKINESIA IN AUSTRALIA: THE 30 YEAR EXPERIENCE OF CONCORD HOSPITAL'S CILIARY STUDIES UNIT', Vol. 20, pp. 116 - 116, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400299&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'THE TWO YEAR EXPERIENCE OF AN AUSTRALIAN PRIMARY CILIARY DYSKINESIA CLINIC', Vol. 20, pp. 116 - 116, presented at Thoracic Society Australia New Zealand Australian New Zealand Society Respiratory Science Annual Scientific Meeting 2015, AUSTRALIA, Queensland, 27 March 2015 - 01 April 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351464400300&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Age and stages of sleep affects surface electromyogram (sEMGdi) of the diaphragm during sleep in children', presented at European Respiratory Society International Congress, Amsterdam, Netherlands, 26 September 2014 - 30 September 2014
,2014, 'REPORT OF THE AUSTRALASIAN REGISTRY NETWORK FOR ORPHAN LUNG DISEASE (ARNOLD)- THE FIRST FOUR YEARS', Vol. 19, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333238100235&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'RHINOVIRUS INFECTIONS IN THE UPPER AND LOWER AIRWAYS OF YOUNG CHILDREN WITH CYSTIC FIBROSIS', Vol. 19, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333238100117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'ELUCIDATING THE MECHANISM OF INTESTINAL INFLAMMATION IN CF: ONE STEP CLOSER', Vol. 48, pp. 404 - 404, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334387200618&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'THE PHENOTYPIC IMPACT OF INTESTINAL INFLAMMATION ON CHILDREN WITH CYSTIC FIBROSIS', Vol. 48, pp. 405 - 405, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334387200619&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'MARKERS OF PAEDIATRIC ASTHMA AND INFLAMMATORY BOWEL DISEASE IN THE BREATH', Vol. 18, pp. 78 - 78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'PREVENTING TOBACCO SMOKING IN DISADVANTAGED AND INDIGENOUS YOUNG PEOPLE', Vol. 18, pp. 17 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'DOES PANCREATIC ENZYME REPLACEMENT THERAPY CAUSE INTESTINAL INFLAMMATION?', Vol. 47, pp. 415 - 415, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308882000607&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'INTRAVENOUS SALBUTAMOL FOR FIRST PRESENTATION OF ASTHMA: DEFINING THE PHENOTYPE AND COMPARING MANAGEMENT', Vol. 17, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000301120800142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2012, 'REPORT OF THE AUSTRALASIAN REGISTRY NETWORK FOR ORPHAN LUNG DISEASE (ARNOLD)-THE FIRST 2 YEARS', Vol. 17, pp. 73 - 73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000301120800279&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'EARLY INTRODUCTION OF ONCE-DAILY INSULIN DETEMIR IMPROVES WEIGHT & LUNG FUNCTION IN INSULIN-DEFICIENT CYSTIC FIBROSIS', pp. 429 - 429, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282988800661&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'ASSOCIATION OF NOCTURNAL HYPOXIA AND ADVERSE CLINICAL STATUS IN CHILDREN WITH CF - CAUSE OR EFFECT?', pp. 349 - 349, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270703400470&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Body composition in 8-12 year-old children with cystic fibrosis assessed longitudinally with a reference four-component model', pp. 386 - 386, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250105000589&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Lung function and body composition in 8 to 12 year-old children with cystic fibrosis', pp. 386 - 387, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000250105000590&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'Development of Lipid/Peptide (Lip/Tide) Vectors for Respiratory Gene Transfer', Vol. 13, pp. S269 - S270, http://dx.doi.org/10.1016/j.ymthe.2006.08.774
,2003, 'Urokinase in the treatment of childhood empyema', Vol. 58, pp. 93 - 93, http://dx.doi.org/10.1136/thorax.58.1.93-a
,1999, 'Active cycle of breathing techniques versus external high frequency oscillations in cystic fibrosis.', Vol. 159, pp. A687 - A687, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082237103828&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,